Patent · US Active

HIV protease inhibiting compounds

US7696226B2 · kind B2 · utility

0Cited by
3References
49Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 10, 2004
Grant dateApr 13, 2010
Priority date—
Expiry dateJun 7, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A compound of the formulais disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.